Tower Research Capital LLC (Trc) Arvinas, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Arvinas, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 8,564 shares of ARVN stock, worth $160,403. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,564
Previous 5,713
49.9%
Holding current value
$160,403
Previous $152,000
38.16%
% of portfolio
0.01%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding ARVN
# of Institutions
229Shares Held
68.4MCall Options Held
226KPut Options Held
285K-
Vanguard Group Inc Valley Forge, PA7.01MShares$131 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$126 Million7.19% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$117 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.85MShares$72.2 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.78MShares$52.1 Million1.09% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $997M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...